Palliative effect of intravesical bacillus Calmette-Guerin in elderly patients with advanced bladder carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9258088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravesical bacillus Calmette-Guerin (BCG) was used to palliate severe local symptoms in patients with invasive carcinoma. Four patients with unresectable bladder carcinoma who were unfit for radical cystectomy because of age and poor performance status were treated with a 6-week course of BCG followed by monthly instillations. Urgency and frequency were reduced in 3 patients and the improvement lasted for 9 to 19 months. All 4 patients ultimately died of bladder carcinoma. The results of palliative BCG treatment were encouraging, but further experience is necessary.
Medical subject headings
- Adjuvants, Immunologic
- BCG Vaccine
- Palliative Care
- Urinary Bladder Neoplasms